Nanoformulated Phytochemicals for PCOS: Therapeutic Potential, Translational Challenges, and Future Perspectives

    June 2026 in “ Health Nanotechnology
    Biplab Debnath, Rajarshi Nath, Joy Das, Priya Chaudhary, Debajit Dewan, Debasmita Paul, Aakriti Patel, Anas Islam, Sathvik Belagodu Sridhar, Uttam Prasad Panigrahy, Md Sadique Hussain, Sumel Ashique
    TLDR Nanoformulated plant compounds show promise for treating PCOS but need more testing and validation.
    The narrative review discusses the potential of nanoformulated phytochemicals as a novel treatment for polycystic ovarian syndrome (PCOS), a complex endocrine and metabolic disorder. Nano-phytochemical delivery systems enhance the solubility, bioavailability, and targeted delivery of bioactive plant components, potentially improving therapeutic efficacy. Preclinical models show promise in using nanocarrier systems to improve metabolic profiles and hormonal balance. However, challenges remain in safety validation, standardization, and legal frameworks. Future directions include well-planned clinical trials and customized treatments. While promising, the approach requires further validation to establish its effectiveness compared to conventional therapies.
    Discuss this study in the Community →

    Research cited in this study

    16 / 16 results